Sector: Health Care
Director information for VIR BIOTECHNOLOGY INC
Board as disclosed in the proxy statement filed April 16, 2026. Titles and roles are as stated in that filing and may have changed since.
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Elliott Sigal, M.D., Ph.D. | 74 | ["M.D.","Ph.D."] | ["Audit","Compensation"] | 2026 | |
| George Scangos, Ph.D. | Ph.D.+ | [] | ["Nominating and Corporate Governance"] | 2026 | |
| Janet Napolitano, J.D. | 68 | [] | ["Audit","Compensation"] | 2026 | |
| Jeffrey S. Hatfield, MBA | 68 | [] | ["Audit","Compensation"] | 2026 | |
| Marianne De Backer | M.Sc., Ph.D., MBA | [] | [] | 2026 | |
| Marianne De Backer | President, Chief Executive Officer and Director | 57 | ["M.Sc.","Ph.D.","MBA"] | [] | 2026 |
| Norbert Bischofberger, Ph.D. | 70 | ["Ph.D."] | ["Audit","Nominating and Corporate Governance"] | 2026 | |
| Ramy Farid, Ph.D. | 61 | ["Ph.D."] | ["Audit","Science and Technology"] | 2026 | |
| Robert More, MBA | 58 | [] | ["Audit","Compensation"] | 2026 | |
| Robert Nelsen | MBA+ | [] | ["Nominating and Corporate Governance"] | 2026 | |
| Saira Ramasastry, M.S. | M.Phil. | 50 | [] | [] | 2026 |
| Vicki Sato, Ph.D. | Board Chair | [] | ["Audit","Compensation"] | 2026 |
